Skip to main content
. Author manuscript; available in PMC: 2011 Jul 1.
Published in final edited form as: Cancer Res. 2010 Jun 8;70(13):5249–5258. doi: 10.1158/0008-5472.CAN-09-2860

Table 1. Surface and intracellular (ic) characterization of the expanded progeny (Mean, +/- SD).

Surface and intracellular phenotyping, PMA/ionomycin induced cytokine secretion was performed as described.(1-3)

Variable IL2 Only IL2 + IL7 p-value*
Day 12-14 Mean-fold expansion 48 +/- 21 165 +/- 123 0.04
%Viable T Lymphocytes among CD45+ events 46 +/- 15 71 +/- 10 0.002
%CD4+ 60 +/- 20 65 +/- 16 0.26
%CD8+ 52 +/- 26 45 +/- 20 0.15
%CD4+/CD8+ 6 +/- 5 3 +/- 3 0.43
ic BCL-2/CD3+ (MFI) 82 +/- 19 82 +/- 16 0.97
% ic Ki67+/CD3+ “proliferating” 50 +/- 14 65 +/- 11 0.003
%ic Ki67+/CD4+ “proliferating” 50 +/- 15 62 +/- 10 0.03
%ic Ki67+/CD8+ “proliferating” 52 +/- 12 68 +/- 11 0.001
% ic Activated Caspase 3+/CD3+ “apoptotic” 8 +/- 3 4 +/- 2 0.011
% ic Activated Caspase 3+/CD4+ “apoptotic” 7 +/- 3 4 +/- 2 0.02
% ic Activated Caspase 3+/CD8+ “apoptotic” 8 +/- 5 4 +/- 2 0.03
%CD25+/CD3+ 62 +/- 14 63 +/- 17 0.95
%CD25+/CD45RO+ 43 +/- 19 25 +/- 28 0.08
%CD28+/CD3+ 89 +/- 5 95 +/- 3 0.02
%CDRA+/RO- “naïve” 45 +/- 30 78 +/- 28 0.06
%CDRA-/RO+ “memory” 10 +/- 4 18 +/- 27 0.65
%CDRA+/CD62L+ “phenotypically naive” 73 +/- 14 90 +/- 5 0.03
%CDRA+/CD27+/CD8+ “naïve CD8+” 79 +/- 7 90 +/- 4 0.003
%CDRA-/CD27+/CD8+ “central memory” 13 +/- 6 4 +/- 2 0.002
%CDRA+/CD27-/CD8+ “effector CTL” 7 +/- 6 6 +/- 4 0.26
%CD57+/CD28-/CD8+ “effector CTL” 0 +/- 0 0 +/- 0 0.35
%HLA-DR+/CD3+ “activated” 46 +/- 12 44 +/- 11 0.53
%HLA-DR+/CD4+ “activated” 45 +/- 12 37 +/- 11 0.1
%HLA-DR+/CD8+ “activated” 45 +/- 16 53 +/- 15 0.003
%NKG2D+/CD3+ 38 +/- 23 27 +/- 20 0.03
%NKG2D+/CD137-/CD8+ “resting” 73 +/- 17 62 +/- 26 0.05
%NKG2D-/CD137+/CD8+ “activated” 1 +/- 2 0 +/- 0 0.32
%NKG2D-/CD137-/CD8+ “anergic” 24 +/- 16 37 +/- 26 0.07
%NKG2D+/CD137+/CD8+ “cytotoxic” 2 +/- 3 1 +/- 1 0.24
% ic GranzymeA+/CD8+ 44 +/- 26 44 +/- 23 0.95
% ic GranzymeB+/CD8+ 41 +/- 35 35 +/- 25 0.26
% ic Perforin+/CD8+ 6 +/- 4 4 +/- 2 0.10
% ic INFγ+/CD3+ 20 +/- 8 19 +/- 10 0.64
% ic TNFα +/CD3+ 50 +/- 20 55 +/- 27 0.65
% ic IL2+/CD4+ 79 +/- 9 54 +/- 36 0.41
% ic IL4+/CD3+ 2 +/- 2 2 +/- 2 0.55
% OX40+/CD4+ 83 +/- 24 78 +/- 21 0.79
*

2-tailed, paired Student t-test

MFI: Mean Fluorescence Index